The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...

The FDA allows compounding pharmacies to sell copies of drugs when the medications are on the agency's shortage list. Now that the FDA has decided tirzepatide is no longer in shortage, companies ...

Although the eggs were initially recalled just five days after distribution on November 27, the FDA reclassified the recall to Class 1 – the agency’s highest alert level – on Friday.

Sally Seymour, director of the FDA’s Division of Pulmonology, Allergy, and Critical Care, said in the FDA announcement. “Many cases of OSA go undiagnosed and untreated, leaving millions at ...

FDA updates "healthy" food labeling rules, requiring limits on added sugars, sodium, and saturated fats for packaged foods. New guidelines align with dietary advances, barring sugary cereals and white ...

The U.S. Food and Drug Administration (FDA) announced that eggs meet the agency's newly updated definition of "healthy.” The FDA created the new definition using current nutrition science and federal ...

On December 10, 2024, the US Food and Drug Administration (FDA) announced the upcoming application round for the Voluntary Qualified Importer Program (VQIP) for fiscal year (FY) 2026. The voluntary, ...

Nuvation Bio (NUVB) announced that the U.S. FDA has accepted the company’s NDA for taletrectinib, an investigational next-generation ROS1 tyrosine kinase inhibitor TKI , for the treatment of ...

FDA Proposes New Testing Rules to Ensure Cosmetics Are Asbestos-Free WASHINGTON (AP) — Cosmetic companies would have to take extra steps to ensure that any products containing talc are free of ...

(RTTNews) - Organon (OGN), Monday announced that the U.S. Food and Drug Administration (FDA) has approved Vtama (tapinarof) cream, an aryl hydrocarbon receptor agonist, for an additional ...

The finding effectively bars widespread sales of cheaper copies of the drugs that many patients use, but the FDA said it would not take any action against the compounding pharmacies that make them ...

The lawsuit, filed in late 2021, attracted attention after the FDA said it could take decades to process and disclose records to Public Health and Medical Professionals for Transparency ...